A 57-year-old woman presents to the emergency department with acute onset confusion, sweating, weakness, and tremors. She says that the symptoms started when she went to dinner with friends and had several drinks of alcohol without eating much food. Her past medical history is significant for type 2 diabetes, and she was recently started on a new medication for this disease. She mentions that her doctor warned her about the risk of low blood sugar, especially if she drinks alcohol or skips meals. Which of the following describes the mechanism of action for the most likely diabetes drug that this patient started taking?

Inhibiting dipeptidyl peptidase

Decreasing hepatic gluconeogenesis

Binding to peroxisome proliferator-activating receptors

A 46-year-old woman presents with palpitations, tremors, and anxiety. She says these symptoms have been present ever since a recent change in her diabetic medication. The most recent time she felt these symptoms, her blood glucose level was 65 mg/dL, and she felt better after eating a cookie. Which of the following is the mechanism of action of the drug most likely to have caused this patient's symptoms?

Blocking of the ATP-sensitive K+ channels

Block reabsorption of glucose in proximal convoluted tubule (PCT)

Inhibitor of dipeptidyl peptidase (DPP-IV)

Decreased hepatic gluconeogenesis

A 45-year-old woman with type 1 diabetes mellitus is brought to the emergency department by her husband because of polyuria, nausea, vomiting, and altered mental status for 4 hours. On arrival, she is unconscious. Treatment with a drug is begun that increases glucose transport to skeletal muscle and adipose tissue. Which of the following cellular events is most likely to also occur in response to this drug?

Dephosphorylation of fructose-1,6-bisphosphatase

Increased activity of acyl-CoA dehydrogenases

Cleavage of UDP from UDP-glucose

Upregulation of glucose transporter type 3 expression

Phosphorylation of glycogen phosphorylase kinase

Certain glucose transporters that are expressed predominantly on skeletal muscle cells and adipocytes are unique compared to those transporters found on other cell types within the body. Without directly affecting glucose transport in other cell types, which of the following would be most likely to selectively increase glucose uptake in skeletal muscle cells and adipocytes?

Increased levels of circulating insulin

Increased plasma glucose concentration

It is physiologically impossible to selectively increase glucose uptake in specific cells

Decreased plasma glucose concentration

Decreased levels of circulating insulin

A group of scientists is studying the mechanism of action of various pancreatic hormones in rats. The scientists studied hormone A, which is secreted by the β-cells of the pancreas, and found that hormone A binds to a complex dimeric receptor on the cell membrane and exerts its effects via phosphorylation and subsequent downstream signaling that includes dephosphorylation of different intracellular proteins. Now they are studying hormone B, which is secreted by the α-cells and antagonizes the actions of hormone A. Which 2nd messenger system would hormone B utilize to exert its cellular effects?

Direct cytoplasmic receptor binding

Direct nuclear receptor binding

You have been asked to deliver a lecture to medical students about the effects of various body hormones and neurotransmitters on the metabolism of glucose. Which of the following statements best describes the effects of sympathetic stimulation on glucose metabolism?

Epinephrine increases liver glycogenolysis.

Norepinephrine causes increased glucose absorption within the intestines.

Without epinephrine, insulin cannot act on the liver.

Peripheral tissues require epinephrine to take up glucose.

Sympathetic stimulation to alpha receptors of the pancreas increases insulin release.

A neurophysiology expert is teaching his students the physiology of the neuromuscular junction. While describing the sequence of events that takes place at the neuromuscular junction, he mentions that as the action potential travels down the motor neuron, it causes depolarization of the presynaptic membrane. This results in the opening of voltage-gated calcium channels, which leads to an influx of calcium into the synapse of the motor neuron. Consequently, the cytosolic concentration of Ca2+ ions increases. Which of the following occurs at the neuromuscular junction as a result of this increase in cytosolic Ca2+?

Exocytosis of acetylcholine from the synaptic vesicles

Generation of an end plate potential

Increased Na+ and K+ conductance of the motor end plate

Binding of Ca2+ ions to NM receptors

Release of Ca2+ ions into the synaptic cleft

A 60-year-old man with type 2 diabetes on metformin and insulin presents with 3 days of nausea, vomiting, and diffuse abdominal pain. He appears ill and confused. Vital signs: BP 95/60 mmHg, HR 115/min, RR 28/min, T 37.2°C. Labs show glucose 380 mg/dL, pH 7.28, HCO3 18 mEq/L, anion gap 24, serum osmolality 310 mOsm/kg, negative urine ketones, creatinine 2.8 mg/dL (baseline 1.1), lactate 8.2 mmol/L. Apply physiological principles to determine the primary acid-base and metabolic disturbance.

Hyperosmolar hyperglycemic state complicated by lactic acidosis from metformin

Sepsis-induced lactic acidosis with stress hyperglycemia

Alcoholic ketoacidosis with concurrent diabetic emergency

Diabetic ketoacidosis with renal failure from volume depletion

Mixed metabolic acidosis from uremia and starvation ketosis

Insulin secretion and action for USMLE Step 2 CK: High-Yield Physiology Lessons

Insulin Synthesis & Secretion - The Sugar Sheriff

Synthesis: In pancreatic β-cells, preproinsulin is cleaved into insulin and C-peptide. Both are stored in granules. C-peptide has a longer half-life than insulin, making it a stable marker.
Secretion Triggers:
- Primary: ↑ Blood glucose is the main driver.
- Potentiators: Incretins (GLP-1, GIP), β₂-adrenergic agonists, vagal stimulation (ACh).
- Inhibitors: Somatostatin, α₂-adrenergic agonists, prostaglandins.

Glucose-Stimulated Secretion Pathway:

Insulin secretion from pancreatic beta-cell

⭐ C-peptide is secreted 1:1 with insulin and is the best measure of endogenous production. This helps distinguish T1DM (low/absent) from T2DM (normal/high) and factitious hypoglycemia.

Insulin's Cellular Action - The Receptor's Reach

Insulin receptor signaling and GLUT4 translocation

Receptor: Cell surface tyrosine kinase receptor (2α, 2β subunits).
Mechanism:
- Insulin binding → receptor autophosphorylation.
- Phosphorylation of Insulin Receptor Substrate (IRS).
- Activation of the PI3K/Akt signaling pathway.
Key Actions:
- Glucose Transport: Rapid translocation of GLUT4 to cell membranes of skeletal muscle and adipose tissue.
- Metabolic Effects (Anabolic):
  - ↑ Glycogen synthesis (liver, muscle).
  - ↑ Protein synthesis.
  - ↑ Lipogenesis.
  - ↓ Gluconeogenesis & lipolysis.

⭐ Insulin-Independent Glucose Uptake: Remember that Brain, RBCs, Intestine, Cornea, Kidney, and Liver (BRICK-L) utilize GLUT1, GLUT2, or GLUT3 and do not depend on insulin for glucose uptake.

Metabolic Effects - Master Fuel Regulator

Insulin is the principal anabolic hormone, promoting fuel storage in the "fed state." It lowers blood glucose by increasing uptake and utilization while inhibiting endogenous production of glucose and fats.

Carbohydrate Metabolism
- ↑ Glucose uptake (muscle, adipose tissue) via GLUT4 translocation.
- ↑ Glycolysis & Acetyl-CoA production.
- ↑ Glycogen synthesis (liver, muscle).
- ↓ Glycogenolysis & gluconeogenesis.
Fat Metabolism
- ↑ Lipogenesis & triglyceride storage (adipose).
- ↓ Lipolysis by inhibiting hormone-sensitive lipase.
- ↓ Ketogenesis.
Protein & Ion Balance
- ↑ Amino acid uptake & protein synthesis (muscle).
- ↑ K+ uptake into cells (activates Na+/K+ ATPase).

⭐ Insulin drives potassium into cells; IV insulin for hyperkalemia can cause iatrogenic hypokalemia if K+ is not co-administered.

Regulation of Secretion - The Control Panel

Primary Stimulus: ↑ Plasma Glucose
Amplifiers (Potentiators):
- Hormonal: Incretins (GLP-1, GIP), β2-adrenergic agonists.
- Neural: Vagal stimulation (ACh).
- Nutrients: Amino acids (arginine, leucine), fatty acids.
Inhibitors:
- Hormonal: Somatostatin, epinephrine (via α2-receptors).
- Neural: Sympathetic stimulation (α2 effect dominates).

Insulin secretion mechanism in pancreatic beta cell

⭐ Exam Favorite: Sulfonylurea drugs (e.g., Glyburide, Glipizide) bypass glucose metabolism and directly close the ATP-sensitive K+ channels to stimulate insulin secretion.

Glucose enters pancreatic β-cells via GLUT2, serving as the primary stimulus for insulin secretion.

↑ATP from glucose metabolism closes ATP-sensitive K+ channels, leading to depolarization and Ca2+-mediated exocytosis of insulin.

Insulin binds to tyrosine kinase receptors, activating the PI3K/Akt pathway.

It promotes GLUT4 translocation to the membrane in muscle and adipose tissue.

Key anabolic effects: ↑glucose uptake, ↑glycogenesis, ↑lipogenesis, and ↑protein synthesis.

Incretins (GLP-1) potentiate release; somatostatin inhibits it.

Continue reading on Oncourse

CONTINUE READING — FREE

or get the app

App Store|Google Play